FOX RUN MANAGEMENT, L.L.C.

Position in NUVL — Nuvalent, Inc.

CIK 1533457 GREENWICH, CT

Position in NUVL

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$837,323

New position

Shares Held

8,173

first reported quarter

Ownership

0.010%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FOX RUN MANAGEMENT, L.L.C. holds $18,757,602 across 55 Biotechnology names. NUVL ranks #2 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	18,715	$897,758
2	NUVL	Nuvalent, Inc. This page	8,173	$837,323
3	RARE	Ultragenyx Pharmaceutical Inc.	37,136	$777,999
4	HALO	Halozyme Therapeutics, Inc.	10,778	$696,582
5	SLNO	Soleno Therapeutics Inc	19,934	$667,390
6	ADMA	Adma Biologics, Inc.	73,991	$666,658
7	ONC	BeOne Medicines Ltd.	2,136	$634,327
8	ELVN	Enliven Therapeutics, Inc.	15,573	$610,461

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$837,323	8,173	—	Shares	Sole	2026-05-12
No filing history on record for this holder in this stock.